Related Experiment Video

Updated: Jun 9, 2025

A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects
05:46

A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects

Published on: May 4, 2021

4.7K

A Novel Common Canister Protocol for Albuterol Sulfate Metered Dose Inhalers: Conservation Strategy and Clinical

Mei Tsai1, Jason Suggett2, Anthony Co1

  • 1Torrance Memorial Medical Center, Torrance, CA, USA.

Hospital Pharmacy
|October 28, 2024
PubMed

Insights

During the COVID-19 pandemic, a novel albuterol sulfate metered dose inhaler (MDI) protocol conserved medication supply. This method improved patient aeration and prevented treatment delays, offering a vital conservation strategy.

Area of Science:

  • Pulmonary Medicine
  • Infectious Disease Management
  • Healthcare Administration

Background:

  • COVID-19 pandemic caused albuterol sulfate metered dose inhaler (MDI) shortages.
  • Increased demand for MDIs due to aerosolization risks with nebulizers.
  • Existing common canister protocols lacked viral cross-contamination quality control.

Purpose of the Study:

  • Evaluate an off-label common canister albuterol sulfate MDI protocol.
  • Assess medication conservation and patient outcomes during a public health emergency.
  • Determine the efficacy of a novel MDI delivery method.

Main Methods:

  • Retrospective review of 329 patients over 10 months (3/2020-1/2021).
  • Utilized an off-label common canister administration via spacer devices.
  • Assessed patient aeration via breath sounds and interviews; reviewed purchasing records.

Main Results:

  • 80.5% of patients (265/329) showed improved aeration.
  • Sufficient MDI supply was maintained; no treatments were delayed or omitted.
  • The protocol successfully conserved albuterol sulfate during the shortage.

Conclusions:

  • The novel common canister MDI approach effectively conserved albuterol sulfate.
  • This method improved patient respiratory status during a public health crisis.
  • The protocol provides a basis for future conservation and quality control studies.
Keywords:
COVIDcritical caredrug/medical use evaluationmedication processrespiratory

More Related Videos

Methodology for Sputum Induction and Laboratory Processing13:28

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

27.5K
Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

2.3K

Related Concept Videos

Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
237
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
182
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.2K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.5K
Administering Oxygen by Nasal Cannula01:29

Administering Oxygen by Nasal Cannula

Oxygen therapy is critical to patient care, especially for those struggling with respiratory issues. This intervention increases the oxygen concentration in the lungs, enhancing the amount of oxygen transported to the body's tissues. One standard method of delivering supplemental oxygen is through a nasal cannula, a non-invasive device that provides low to medium oxygen concentrations.
Nasal Cannulas
A nasal cannula is a lightweight tube split into two prongs placed in the nostrils,...
407